Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chiarini

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
International Journal of Immunopathology and Pharmacology|October 8, 2011
Antibacterial activity of methyl aminolevulinate photodynamic therapy in the treatment of a cutaneous ulcerV Devirgiliis, V Panasiti, D Fioriti, et al.
Leukemia|May 23, 2012
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemiaC Simioni, L M Neri, G Tabellini, et al.
Leukemia|December 7, 2013
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemiaA Lonetti, I L Antunes, F Chiarini, et al.
Leukemia|March 5, 2010
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanismsA M Martelli, V Papa, P L Tazzari, et al.
Leukemia|October 5, 2011
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implicationsC Grimaldi, F Chiarini, G Tabellini, et al.
Leukemia|November 21, 2013
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signalingF Buontempo, E Orsini, L R Martins, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
International Journal of Immunopathology and Pharmacology|October 8, 2011
Antibacterial activity of methyl aminolevulinate photodynamic therapy in the treatment of a cutaneous ulcerV Devirgiliis, V Panasiti, D Fioriti, et al.
Leukemia|May 23, 2012
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemiaC Simioni, L M Neri, G Tabellini, et al.
Leukemia|December 7, 2013
Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemiaA Lonetti, I L Antunes, F Chiarini, et al.
Leukemia|March 5, 2010
Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanismsA M Martelli, V Papa, P L Tazzari, et al.
Leukemia|October 5, 2011
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implicationsC Grimaldi, F Chiarini, G Tabellini, et al.
Leukemia|November 21, 2013
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: targeting the unfolded protein response signalingF Buontempo, E Orsini, L R Martins, et al.
Pageof 8